Endocyte Inc. buy melinda
Start price
26.02.18
/
50%
€3.85
Target price
28.02.18
€5.41
Performance (%)
28.73%
End price
28.02.18
€4.96
Summary
This prediction ended on 28.02.18 with a price of €4.96. The prediction had a final performance of 28.73%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endocyte Inc. | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,98 % | 8,98 % | 49,86 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % | 38,41 % | 100,33 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % | 46,68 % | 65,35 % |
| iShares S&P 500 | 0,97 % | 7,62 % | 28,14 % | 68,66 % |
Comments by melinda for this prediction
In the thread Endocyte Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten

(Vom Mitglied beendet)


